| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |